AccelPath, Inc. Company Profile
AccelPath provides technology solutions that play a key role in delivering information required for diagnosis of diseases and other pathologic conditions with and through its associated institutional pathologists. The medical institutions, with whom the Company partners, prepare comprehensive diagnostic reports of a patientâs condition and consult with referring physicians to help determine the most appropriate treatment. Such diagnostic reports enable the early detection of disease, allowing referring physicians to make informed and timely treatment decisions that improve their patientsâ health in a cost-effective manner. The Company seeks out referring physicians and histology laboratories in need of high-quality pathology interpretations and manages HIPAA-compliant digital case delivery and reporting while developing comprehensive solutions for managing medical information.
News Articles
AccelPath takes over digital telepathology service provider
AccelPath has completed the purchase of US-based provider of digital telepathology and laboratory development and management services, DigiPath Solutions, for $2.4m.
AccelPath, Inc. Acquires DigiPath Solutions, LLC
AccelPath, Inc. (OTCBB: ACLP) (“AccelPath” or the “Company”), a leading provider of digital telepathology services, announced today that it has acquired privately held Dig...
Please replace the release with the following corrected version due to multiple revisions. The corrected release reads: ACCELPATH, INC. IN DISCUSSIONS WIT...
AccelPath, Inc. (OTCBB: ACLP) (“AccelPath” or the “Company”) announced today that the Company has been approached by several contractors, who have winning bids relating to...
AccelPath, Inc. Working with Three Pathology Laboratories
AccelPath, Inc. (OTCBB: ACLP) (“AccelPath” or the “Company”) announced today that the Company is working with three pathology laboratories in Texas. The th...
AccelPath, Inc. (OTCBB: ACLP) (“AccelPath” or the “Company”) announced today that Professor Leslie F. Greengard, M.D., Ph.D., has been appointed to the Company’s Medical...
AccelPath, Inc. Letter to Shareholders
AccelPath, Inc. (OTCBB: ACLP) (“AccelPath” or the “Company”) issued the following Letter to Shareholders today outlining the Company’s overall business strategy and oper...
AccelPath, Inc. (OTCBB: ACLP) (“AccelPath” or the “Company”) announced today that Dr. Keith J. Kaplan, M.D. continues his role as Chairman and active member of the Company...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
AccelPath provides technology solutions that play a key role in delivering information required for diagnosis of diseases and other pathologic conditions with and through its asso...
More Information about "AccelPath, Inc." on BioPortfolio
We have published hundreds of AccelPath, Inc. news stories on BioPortfolio along with dozens of AccelPath, Inc. Clinical Trials and PubMed Articles about AccelPath, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of AccelPath, Inc. Companies in our database. You can also find out about relevant AccelPath, Inc. Drugs and Medications on this site too.
